All Pathways
Obstetrics & GynecologyManagement

Pelvic Inflammatory Disease Management (CDC 2021)

Pelvic Inflammatory Disease Management (CDC 2021): Suspected PID → Diagnostic Criteria → Diagnostic Workup → Severity Assessment → Inpatient Criteria.

Pathway Overview

12 steps

Algorithm Steps

12 total

  1. 01Start

    Suspected PID

    Lower abdominal/pelvic pain in sexually active patient

  2. 02Action

    Diagnostic Criteria

    Minimum criteria for empiric treatment

    • MINIMUM CRITERIA (any one):
    • - Cervical motion tenderness
    • - Uterine tenderness
    • - Adnexal tenderness
    • ADDITIONAL CRITERIA (support diagnosis):
    • - Temp >38.3°C (101°F)
    • - Mucopurulent cervical discharge
    • - WBC on wet prep
    • - Elevated ESR or CRP
    • - Lab evidence of GC or chlamydia
  3. 03Action

    Diagnostic Workup

    Rule out emergencies, obtain cultures

    • Pregnancy test (rule out ectopic)
    • NAAT for GC and chlamydia
    • Wet prep/vaginal microscopy
    • HIV testing
    • Consider: CBC, CRP, urinalysis
    • Pelvic ultrasound if TOA suspected
  4. 04Decision

    Severity Assessment

    Inpatient vs outpatient management

  5. 05Action

    Inpatient Criteria

    Admit if any present

    • Surgical emergency not excluded (appendicitis, ectopic)
    • Pregnant
    • Unable to tolerate oral meds (N/V)
    • Severe illness, high fever, peritonitis
    • Tubo-ovarian abscess
    • Failed outpatient therapy
  6. 06Action

    Inpatient IV Treatment

    Parenteral regimens

    • REGIMEN A:
    • Ceftriaxone 1g IV q24h + Doxycycline 100mg IV/PO q12h + Metronidazole 500mg IV/PO q12h
    • REGIMEN B:
    • Cefoxitin 2g IV q6h + Doxycycline 100mg IV/PO q12h
    • Transition to oral after 24-48h improvement
  7. 07Action

    Follow-Up

    Essential for all patients

    • 72-hour follow-up for clinical improvement
    • Partner treatment (expedited partner therapy)
    • STI counseling and education
    • Retest for GC/chlamydia in 3 months
    • Counsel on fertility implications
  8. 08Outcome

    Resolution

    Complete antibiotic course, test of cure

  9. 09Action

    Outpatient Treatment

    CDC 2021 recommended regimen

    • Ceftriaxone 500mg IM x1 (1g if ≥150kg)
    • PLUS Doxycycline 100mg PO BID x 14 days
    • PLUS Metronidazole 500mg PO BID x 14 days
    • Alternative cephalosporin + probenecid options available
    • Follow-up in 72 hours essential
  10. Path rejoins step 07Shared downstream outcome
  11. 10Warning

    Partner Notification

    All sex partners in past 60 days

    • Evaluate and treat presumptively
    • Expedited partner therapy if allowed
    • Abstain from intercourse until treatment complete
  12. 11Decision

    Tubo-Ovarian Abscess?

    Ultrasound or clinical suspicion

  13. 12Action

    TOA Management

    May require drainage

    • IV antibiotics initially
    • Consider interventional drainage if >6-8cm
    • Surgical management if ruptured
    • Follow with imaging for resolution
    • May require prolonged antibiotics
  14. Path rejoins step 07Shared downstream outcome

Guideline Source

CDC Sexually Transmitted Infections Treatment Guidelines 2021

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • PID is a clinical diagnosis - no gold standard test
  • Treatment empiric - culture results take days
  • Partner notification essential
  • Tubo-ovarian abscess requires additional management

Applicable Regions

USGlobal
Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Pelvic Inflammatory Disease Management (CDC 2021)?

The Pelvic Inflammatory Disease Management (CDC 2021) is a management clinical algorithm for Obstetrics & Gynecology. It provides a structured decision tree to guide clinical decision-making, based on CDC Sexually Transmitted Infections Treatment Guidelines 2021.

What guideline is the Pelvic Inflammatory Disease Management (CDC 2021) based on?

This algorithm is based on CDC Sexually Transmitted Infections Treatment Guidelines 2021 (DOI: 10.15585/mmwr.rr7004a1).

What are the limitations of the Pelvic Inflammatory Disease Management (CDC 2021)?

Known limitations include: PID is a clinical diagnosis - no gold standard test; Treatment empiric - culture results take days; Partner notification essential; Tubo-ovarian abscess requires additional management. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Pelvic Inflammatory Disease Management (CDC 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free